Compliance Essentials for Post-Marketing Surveillance | OMC Medical Limited

Compliance in post-marketing surveillance is paramount for OMC Medical Limited to ensure product safety and regulatory adherence. Monitoring adverse events, product complaints, and ensuring timely reporting to regulatory authorities are key pillars. Rigorous documentation and adherence to Good Pharmacovigilance Practices (GVP) are essential. OMC Medical Limited must establish clear procedures for signal detection, risk assessment, and risk minimization strategies. Continuous training of personnel on compliance requirements is crucial to maintain vigilance.